Indian pharmaceutical stocks may experience a potential resurgence in 2024, driven by increasing exports, strategic shifts in global markets, and a rising demand for affordable healthcare. Let’s explore the key drivers behind this resurgence and highlight the companies to watch as the industry charts a promising path forward.

The stage is set for the water infra industry as Budget 2024 floods the space with massive funding. Here’s what you need to know…

India's push towards becoming carbon neutral by 2070 has opened up a massive opportunity for electrical vehicle (EV) battery reuse and recycling.

Tupperware, once a symbol of premium kitchenware and social gatherings in Indian homes, is now facing a global decline due to missed digital opportunities and outdated business models. This article explores the red flags for investors and why Tupperware's Indian operations may still hold promise despite their global struggles.

Sarvam AI is transforming AI in India by enabling multilingual accessibility across Hindi, Tamil & more. Discover its impact on India's GenAI market growth with Kotak Securities.

Remember the days when space was just for a few big government agencies with billion-dollar budgets?